= Receptor phosphorylation assay
A <receptor phosphorylation assay> asks whether, and how much, a specified <receptor> is modified by <phosphorylation> under defined conditions. It is distinct from a binding assay for <receptor binding occupancy>, a test of <protein kinase> activity on a supplied <substrate>, and a test of downstream <signal transduction>. Those measurements answer related but different questions.
For a <Western blot> implementation, compare matched samples with <ligand> omitted or added, detect a specified phosphorylated <epitope>, and separately detect total <receptor> abundance. Preserve the sampled state by stopping further <enzyme> reactions during sample preparation; otherwise <protein kinase> or <protein phosphatase> activity after sampling can change the result. A general anti-<phosphotyrosine residue> <antibody> recognizes many modified <proteins>; a site-selective <antibody> gives a narrower readout, but still needs <Western blot antibody specificity controls>.
Reason through the controls before interpreting the difference. Loss of the proposed signal after receptor-specific <gene deletion> supports <protein> identity. Treatment with a <protein phosphatase>, alongside preservation of the total-<receptor> signal, tests phosphate-dependent recognition. <Western blot loading controls> and <Western blot transfer controls> address sample recovery; a usable detection range addresses <Western blot response saturation>. Lower signal after perturbing <protein kinase> activity supports dependence on that perturbation, but alternative targets and altered <receptor> abundance can complicate the inference. These are proposed assay comparisons, not outcomes attributed to the historical membrane experiment.
\Image[/receptor-phosphorylation-assay-control-logic.png]
{title=Controls connecting a <receptor phosphorylation assay> to a defensible inference}
{description=Original reasoning diagram for a <Western blot> implementation. Separate comparisons address <protein> identity, phosphate-dependent <epitope> recognition, recovery and detection response. Boxes prescribe questions; they contain no measured bands, observed experimental outcomes or synthetic time course.}
An original idealized measurement model explains the normalization. Let $N$ be the retained number of <receptor> <molecules>, $f$ the fraction carrying the selected modified <epitope>, and $c_p,c_t>0$ fixed detection gains. After subtracting their respective backgrounds, suppose the phosphorylated and total-<receptor> signals lie in a linear response range:
$$
A=c_pNf,\qquad B=c_tN,\qquad \frac{A}{B}=\frac{c_p}{c_t}f.
$$
Dividing by total <receptor> cancels $N$ under these assumptions. It differs from total-<protein> <Western blot normalization>, whose denominator includes many other <proteins>. For invented values $c_p=c_t=1$, samples with $(N,f)=(100,0.2)$ and $(200,0.2)$ give $A=20$ and $40$, but both give $A/B=0.2$. Twice the phospho signal here means twice the retained <receptor> amount, with no change in fractional modification. Unequal recovery, changed <epitope> accessibility, nonzero uncorrected background or <Western blot response saturation> invalidates the cancellation. Unknown relative gains prevent reading an absolute modified fraction directly from the <ratio>.
Back to article page
